An observational study in CMV Infection, sponsored by Emilio Bouza. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-12-24.
Sponsored by Emilio Bouza · Observational
Prospectively assessment of CMV viremia by real-time polymerase chain reaction (PCR) in a broad cohort of consecutive immunocompetent adults admitted to a major heart surgery intensive care unit (MHS-ICU) with the goal of determining the epidemiology, risk factors, and clinical significance of CMV infection.
6,686 studies on the registry are indexed under Infections; 807 are open to participants now.
This study's enrollment of 150 is below the median of 240 across 2,136 observational studies indexed under Infections.
Browse Infections studies →Emilio Bouza is the lead sponsor of 5 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
immunocompetent adults admitted to a major heart surgery intensive care unit
Exclusion Criteria:
incidence number of participants with a positive CMV positive result
Time frame: month 8
risk factors for CMV reactivation
Time frame: month 8
mortality by day 30
composite endpoint. hospitalization or death by day 30
Time frame: month 8
prolonged hospitalization . More than 30 days
Time frame: month 8
This study is completed, as verified in Dec 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Emilio Bouza